Stock AADI AADI BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Aadi Bioscience, Inc.

Equities

AADI

US00032Q1040

Real-time Estimate Cboe BZX
Other stock markets
 02:26:02 2024-05-21 pm EDT 		5-day change 1st Jan Change
1.855 USD -0.27% Intraday chart for Aadi Bioscience, Inc. -1.06% -7.92%
May. 08 Aadi Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 08 Earnings Flash (AADI) AADI BIOSCIENCE Reports Q1 Revenue $5.4M MT

Evolution of the average Target Price on Aadi Bioscience, Inc.

Price target over the last 5 years

History of analyst recommendation changes

886ce04b1013147435.0Ua2TVpjySAumJObLP7DHKg6XFYgSUIFT2gENeOJM-g.uXDjeRwl8VhF-6TjaLfzbsNCLQJIPzpUfxJAQ5W_W7imf8J5MxmKeW39yg~751381b5cf65937e6c5f06d383de8034

Analyst Recommendations on Aadi Bioscience, Inc.

Piper Sandler Cuts Aadi Bioscience's Price Target to $5 From $30, Keeps Overweight Rating MT
HC Wainwright Downgrades Aadi Bioscience to Neutral From Buy MT
HC Wainwright Adjusts Price Target on Aadi Bioscience to $45 From $48, Maintains Buy Rating MT
HC Wainwright Adjusts Aadi Bioscience's Price Target to $48 from $49, Keeps Buy Rating MT
Jefferies Starts Aadi Bioscience at Buy With $45 Price Target MT
HC Wainwright Adjusts Aadi Bioscience's Price Target to $49 From $47, Keeps Buy Rating MT
AADI BIOSCIENCE : Cowen Starts Aadi Bioscience at Outperform MT
AADI BIOSCIENCE : Ladenburg Thalmann Initiates Coverage on Aadi Bioscience With Buy Rating, $51 Price Target MT
AADI BIOSCIENCE : Piper Sandler Starts Aadi Bioscience at Overweight With $45 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.86 USD
Average target price
11 USD
Spread / Average Target
+491.40%
High Price Target
14 USD
Spread / Highest target
+652.69%
Low Price Target
5 USD
Spread / Lowest Target
+168.82%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Aadi Bioscience, Inc.

Piper Sandler
HC Wainwright
Jefferies & Co.
Cowen
Ladenburg Thalmann

Ratings for Aadi Bioscience, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AADI Stock
  4. Consensus Aadi Bioscience, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW